Valcyte 50 mg/ml pulver til oral opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

valcyte 50 mg/ml pulver til oral opløsning

cheplapharm arzneimittel gmbh - valganciclovirhydrochlorid - pulver til oral opløsning - 50 mg/ml

Valganciclovir "Accord" 450 mg filmovertrukne tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

valganciclovir "accord" 450 mg filmovertrukne tabletter

accord healthcare b.v. - valganciclovirhydrochlorid - filmovertrukne tabletter - 450 mg

Valganciclovir  "Orion" 450 mg filmovertrukne tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

valganciclovir "orion" 450 mg filmovertrukne tabletter

aurobindo pharma (malta) limited - valganciclovirhydrochlorid - filmovertrukne tabletter - 450 mg

Valganciclovir "Medical Valley" 450 mg filmovertrukne tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

valganciclovir "medical valley" 450 mg filmovertrukne tabletter

medical valley invest ab - valganciclovirhydrochlorid - filmovertrukne tabletter - 450 mg

Cancidas (previously Caspofungin MSD) Avrupa Birliği - Danca - EMA (European Medicines Agency)

cancidas (previously caspofungin msd)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika til systemisk brug - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.